Alpha-Defensins Research for Inflammatory Bowel Disease
An evidence-based overview of research examining Alpha-Defensins in the context of inflammatory bowel disease. This page synthesizes findings from peer-reviewed literature.
Research Summary
Reduced Paneth cell defensin expression (HD-5, HD-6) has been observed in Crohn's disease patients, particularly those with ileal involvement. This deficiency may contribute to dysbiosis and mucosal barrier dysfunction. Research suggests defensin levels may serve as biomarkers for disease activity.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Inflammatory Bowel Disease
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Alpha-Defensins may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.